ArticleDiscover oncology2026
Impact of the surgery to radiotherapy interval on oncological outcomes in squamous cell carcinoma of the oral tongue.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
BACKGROUND AND
aimsThis study aimed to explore the relationship between the timing of radiotherapy (RT) initiation after surgery and long-term outcomes in patients with tongue squamous cell carcinoma (TSCC).
methodsWe retrospectively analyzed TSCC Patients who underwent external beam radiotherapy (≥ 60 Gy) following surgical resection without evidence of distant metastasis. Patients were categorized according to tumor stage and the interval between surgery and start of RT. The primary outcomes assessed were loco-regional control (LRC), disease-free survival (DFS), and overall survival (OS).
resultsA total of 108 patients were included. Among early-stage TSCC patients, delaying RT beyond 47 days post-surgery showed no statistically significant difference in DFS. For patients with locally advanced-stage disease, a longer interval between surgery and RT was associated with a significant trend toward improved DFS. OS did not significantly differ based on RT timing across stages.
conclusionsOur findings suggest that modest delays in initiating postoperative RT may not adversely affect DFS or OS in early-stage TSCC, and longer intervals may not clearly determine poorer outcomes in advanced-stage disease. However, these observations are preliminary and should be interpreted with caution given the small sample size, limited number of events, and retrospective design. Larger prospective studies are required to test this hypothesis and clarify optimal timing of postoperative RT in TSCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.